Vascular Malformations Clinical Trials in Baltimore, Maryland
2 recruitingBaltimore, Maryland
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
PIK3CA MutationVascular MalformationsPIK3CA-Related Overgrowth Spectrum (PROS)+4 more
Relay Therapeutics, Inc.277 enrolled31 locationsNCT06789913
Recruiting
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
Vascular MalformationsVM - Vascular Malformation
Johns Hopkins University200 enrolled1 locationNCT04104464